The c-fos and c-jun proto-oncogenes were originally identified as the cellular counterparts of the viral oncogenes carried by Finkel-Biskis-Jinkins (FBJ) murine sarcoma virus (11) and avian sarcoma virus 17 (21) , respectively. c-fos belongs to a multigene family that includesfra-1 (9) ,fra-2 (23, 27) , andfosB (42) , and the fos gene family codes for nuclear proteins that dimerize with the Jun family proteins, such as c-Jun (26) , JunB (33) , and JunD (16, 32) , to form the transcription factor complex AP-1. Dimerization occurs specifically through a leucine zipper structure: Jun family members can form lowaffinity homodimers and high-affinity heterodimers with the Fos family, whereas Fos-related proteins do not form stable homodimers (10, 25) . Although these hetero-and homodimers bind to similar DNA-binding sites (TGACTCA, AP-1-binding sites) through the basic domains of both proteins, which are juxtaposed by the dimerization, each dimer was shown to have a distinct transcriptional regulatory function, so that transcription can be positively and negatively modulated (37) .
High-level expression of most members of the fos or jun gene family has been reported to cause cellular transformation of chicken embryo fibroblasts (CEF) (17, 27, 36) . JunD has no transforming activity, but it can acquire transforming potential by spontaneous mutation (15, 18) . These results indicate that uncontrolled expression and qualitative change of any component of AP-1 can induce cellular transformation.
Logarithmically growing CEF express c-Jun and Fra-2 at relatively high levels (36, 41) , and basal-level expression of JunD was also reported in these cells (14) . In c-fos-overexpressing cells, cellular transformation seems to be mediated by the heterodimeric complex of exogenous c-Fos and endogenous c-Jun (38) . In the case of transforming junD mutants, it was suggested that the heterodimeric complexes of endogenous Fra-2 and JunD mutants play a crucial role in cellular transformation (18) .
In our previous attempt to suppress specifically the transcriptional function of c-jun, we constructed a transdominant mutant designated supfos-1 (28) . supfos-1 was originally described as a nontransforming v-fos mutant (40) which has an insertion of four amino acids between the basic domain and the leucine zipper structure (Fig. 1) , and its gene product was shown, both in vitro and in vivo, to form a heterodimer with c-Jun that lacks the specific AP-1 DNA binding (28) . This mutant, when introduced by retrovirus vectors, efficiently suppresses c-jun transformation by sequestering the unstable c-Jun homodimer into the stable and nonfunctional supFoslJun heterodimer in the cells. Interestingly, nuclear extracts from the supfos-1-expressing CEF reduced endogenous AP-1 DNA-binding activity (mainly contributed by Fra-2-Jun) to an almost nondetectable level by competing out endogenous Fra-2 (27) , suggesting that this mutant can also function as an inhibitor of Fos family proteins. Several fos or jun mutants have also been reported by other groups to function as transdominant suppressors by a mechanism similar to that used by supfos-1 (38) . Some of the transdominant mutants, however, function without the leucine zipper structure, possibly by a squelching mechanism (38) , while others retain both dimer-forming and DNA-binding activities but lack the transactivation domain (6, 13, 20 (17) to generate pHras. pND-raf was generated from the human c-raf-1 cDNA, p627 (from JCRB) (5) , by PCR using a 5' primer that covers the artificial methionine codon preceded by an artificial Kozak consensus sequence and a BamHI site (5'-AGGGATCCACCATGGAA AGAGAGCGGCACCAGT-3') and a 3' primer that contains the stop codon (5'-CCGGATCCCTACTAGAAGACAGGCA GCCTCGG-3'). The PCR product was digested with BamHI and inserted into the unique BglII site of pDS3. pND-raf encodes the same amino acid sequence as the 20A clone constructed by Stanton et al. (35) , which lacks the N-terminal 313 amino acids of human c-raf. The 0.5-kb NaeI-EcoT4I fragment of pHJ (gift from R. Tjian) (4) was filled in, ligated to BglII linkers, and inserted into the BglII site of pDS3 to generate psupjun-1, which produces an N-terminally truncated Jun from the internal methionine 247. The truncated Jun retains the entire basic domain and the intact leucine zipper structure, as shown in Fig. 1 . The 0.83-kb EcoRI-BspMI fragment of pSPfra-1 (rat) (9) was filled in and ligated with blunt-ended BglII-cut pDS3 to generate pFlR1, which carries the entire rat fra-] gene.
For RNA probe synthesis, four DNA templates were constructed. The 450-bp BstXl-EcoRI fragment of pJun (gift from P. Vogt) (21) encoding the C-terminal half of the v-jun gene was cloned into pBlueskm to generate pjunRPA, which was linearized at the PvuII site and used as a template. The 260-bp PstI-SacI fragment of chicken v-fos (12) was inserted into pSPT19 to generate pfosRPA, which was linearized at the NdeI site and used as a template. The 250-bp BstEI-NcoI fragment of chicken fra-2 (26) was filled in and ligated to pSP64, whichwas doubly digested with EcoRI andBamHI and blunt ended, to generate pfra2RPA. The pfra2RPA was linearized at the Pvull site and used as a template. The chicken junD construct was generated by PCR, using the published sequence (14) . The 245-bp SadH-TaqI fragment of the PCR product was inserted between the AccI and SacII sites of pBlueskm to generate the pjunDRPA. pjunDRPA was linearized at the intemal DdeI site and used as a template. For Northem (RNA) blotting of the chicken glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA, the c-DNA that encodes the entire GAPDH was generated by the reverse transcription RT-PCR technique, using the published sequence (29) .
Cells and viruses. CEF were prepared, grown, and infected with viruses as reported previously (28) . For metabolic labeling, CEF were grown in 60-min-diameter dishes and labeled with 500 ,uCi of [35S]methionine for 60 min. For the production of recombinant viruses such as supjun-1 (carrying N-terminally truncated jun), ND-raf (carrying N-terminally deleted raf), and H-ras (carrying normal c-Ha-ras) viruses, psupjun-1 and pHras were completely digested with Sall and ligated to the Sall J. VIROL. digest of pREP to form the structure of the replicationcompetent provirus (subgroup A); pND-raf was partially digested with Sall, and a 1.3-kb fragment that covers the raf sequence was isolated and used for ligation with the Sall digest of pREP. Ligated DNAs (2 jig) were transfected into CEF as described previously (17), and replication-competent virus stocks were collected from the culture 5 or 6 days after transfection. Viruses were never propagated before use to minimize genetic changes of the virus genome. For production of the subgroup B virus, pREP was substituted with pREP-B. Similar viruses containing the human c-jun gene (JH-1 [36] ), the mouse c-fos gene (FM4 [17] ), the chickenfra-2 gene (F2C1 [27] ), the v-src gene of Rous sarcoma virus (N4 [17] Colony formation. CEF that were sequentially infected with two species of viruses were trypsinized 4 days after the second infection. Approximately 3,000 doubly infected CEF were mixed with 3 x 105 freshly prepared CEF feeder cells and seeded in suspension in soft agar (0.4%) on top of a bed of hard agar (0.8%) as discussed previously (28) . Colonies, which were formed after 2 weeks of incubation at 38.5°C, were counted (average of three plates) at 3 weeks after seeding.
Gel shift analysis. Gel shift analysis using proteins synthesized in rabbit reticulocyte and using a 32P-labeled 62-bp double-stranded DNA probe containing the FSE2 AP-1 DNAbinding site was described previously (37) .
The nuclear extracts were prepared from infected CEF as described previously (28) . Gel shift analysis of the nuclear extract was done as described previously (28, 41) , using a 32P-labeled 65-bp HindIll-Aval fragment of pcoll, which has an insertion of an oligonucleotide containing the AP-1 DNAbinding site of the human collagenase gene at the BamHI site of pUC119. In some experiments, the antiserum was added to the mixture 15 jig of RNase T, per ml at 42°C, samples were analyzed in 6 M urea-polyacrylamide gels and detected by autoradiography.
RESULTS
Another highly effective transdominant mutant, supJun-1.
To obtain effective transdominant mutants other than supfos-I (Fig. 1) , we tested some nontransforming mutants offos orjun described here or previously (40) for the ability to suppress c-jun transformation, using the method previously described for supfos-J (28). To introduce c-jun and the candidate mutant into a single cell, we used replication-competent retrovirus vectors as described previously (28) . Two sets of vectors that differed in subgroup specificity (A or B) were created for each gene. CEF are resistant to infection by retroviruses of the same subgroup, but they can be superinfected by retroviruses of a different subgroup. Thus, it was possible to obtain large populations of doubly infected CEF expressing both c-Jun and the candidate mutant at similar levels without any selection procedure.
One mutant, designated supjun-1, which lacks the entire transactivation domain ( (Table   1) . Similar results were obtained when JH-1 was substituted for T2 and T3 viruses (Table 1) , which encode transforming junD mutants.
Although supJun-1 protein lacks all regions that have been reported to function as transactivation domains (3), it should have specific DNA-binding activity, because it retains the entire basic region and the intact leucine zipper structure. This was confirmed by gel shift analysis (Fig. 2) of the mixture of supJun-1 and wild-type Jun which were produced in vitro; three specific band shifts were generated by the supJun-1 homodimer, the supJunl-c-Jun heterodimer, and the c-Jun homodimer. This result is in a clear contrast to supFos-1, which was shown to have no DNA-binding activity (28) , and we decided to compare the two mutants in a further analysis.
Either supfos-1 or supjun-1 can function as a general inhibitor of AP-1 activity. We next tested whether supfos-I or supjun-1 can suppress not only c-jun transformation but also transformation induced by oncogenes that belong to the fos family. We previously reported the full transforming activity of FM4 and F2C1 viruses, which carry c-fos (mouse) (17) and fra-2 (chicken) (27) , respectively. The fra-1-carrying virus constructed here (FiR1) exhibited similar transforming activity, as judged from the titer of transforming virus in the virus stock or its efficiency of colony formation in soft agar (data not shown). As is the case with c-jun, the transformation induced by c-fos, fra-1, and fra-2 was efficiently suppressed by subsequent infection with supfos-J or supjun-1 when judged by colony-forming activity ( Fig. 4D was divided by that formed by DS3(A)/FM4(B)-infected CEF (Fig. 4A ).
The ratio shown is the average of three independent experiments. ND, not determined.
"The experimental protocol in which transforming virus was infected and supfosl was infected subsequently. 
supjun-J(A) (D to F) and 4 days later superinfected with FM4(B) (A and D), H-ras(B) (B and E), or N4(B) (C and F). At 4 days after
superinfection, they were trypsinized, seeded into soft agar (60-mm-diameter plates), and propagated for 3 weeks at 38.5°C before being photographed.
was suppressed by the transdominant mutants. Using these inhibitors of AP-1, we next screened CEF transformed by a series of naturally isolated or recombinant transforming retroviruses to test whether endogenous AP-1 function is essential for their transformation. Among the recombinant viruses, H-ras and ND-raf were constructed in this study and encode the normal human Harvey c-ras gene or N-terminal truncated human c-raf, respectively. Both viruses transformed CEF moderately, as judged from the morphological changes ( Fig. 3C and D) and titer of focus formation [around 105 focus-forming units/ml for H-ras(A) or ND-raf(A)]. These results are in good agreement with those observed in murine cell lines (8, 35) .
As shown in Table 1 and Fig. 4 , supfos-1 and supjun-1 can efficiently suppress colony formation in soft agar caused by v-src, v-yes, v-fps, c-Ha-ras, and ND-raf, though in all of these cases, suppression by supjun-J was stronger than suppression by supfos-1. On the other hand, colonies formed by v-myc or v-ros were never suppressed by superinfection with either of these transdominant mutants. The reduction of anchorageindependent growth of the doubly infected CEF is in good agreement with the reversion to the normal cellular morphology in monolayer cultures, some examples of which are shown in Fig. 3 (compare Fig. 3C to E with Fig. 3H to J, respectively) . In the v-src-introduced culture, however, partially refractile cells were still detectable (Fig. 3J) , and their population increased gradually when the cultures were maintained for longer periods of time. It is also noteworthy that CEF transformed by v-myc or v-ros did not revert to the normal morphology upon superinfection with these two transdominant mutants (data not shown).
Analysis of the AP-1 components in CEF transformed by several oncogenes. As discussed above, we categorized seven oncogenes into two groups by using transdominant mutants; five (v-src, v-yes, v-fps, ND-raf, and c-H-ras) require endogenous AP-1 activity for their transforming activity, while two (v-ros and v-myc) do not. Since either of the two transdominant mutants used in this study can function as a general inhibitor of AP-1, we next analyzed all known chicken AP-1 components (c-fos, fra-2, c-jun, and junD) in cells transformed by several oncogenes to examine the molecular mechanisms by which AP-1 is involved in cellular transformation.
From logarithmically growing CEF, we prepared total cell extracts and analyzed the absolute amounts of endogenous Jun and JunD by immunoblotting with an anti-Jun antiserum that is cross-reactive to JunD (Fig. 5A) . Compared with DS3-infected or uninfected CEF, CEF transformed by v-src, v-fps, and v-ros expressed three-to fourfold more c-Jun, while about twofold-greater expression was observed in v-yes-, c-Ha-ras-, and ND-raf-transformed CEF. It should be pointed out that the c-jun-transformed CEF expressed much higher levels of exogenous human c-Jun (about five times the endogenous c-Jun level). On the other hand, v-myc-transformed CEF expressed a similar level of c-Jun, comparable to DS3-infected or uninfected CEF. The JunD bands were too weak compared with c-Jun bands to allow comparison of the expression levels among these cells quantitatively.
For analysis of endogenous c-Fos and Fra-2, logarithmically growing CEF were metabolically labeled with [35S]methionine.
From cellular lysates prepared under denaturing conditions, proteins were immunoprecipitated with the anti-Fra-2 antiserum, which specifically precipitates Fra-2 (Fig. SB) , and the anti-Fos antiserum, which precipitates all Fos family proteins. None of the logarithmically growing CEF showed any detectable c-Fos expression (data not shown), but basal expression of Fra-2 was detectable in all cells. In CEF transformed by v-src, ND-raf, and c-H-ras, Fra-2 formed a broad band of 41 to 46 kDa, compared with a sharper, thin band of 41 to 42 kDa detected in DS3-infected CEF. After bacterial alkaline phosphatase treatment of the immunoprecipitates, the protein bands of all cells migrated as sharp bands, indicating that the slowly migrating population of the protein represents hyperphosphorylated forms (Fig. 5B) as we have previously observed in Fra-2 immediately after growth stimulation (39) . Elevated levels of Fra-2 and Jun proteins result from regulation at the transcriptional level. CEF transformed by v-src, ND-raf, and c-Ha-ras expressed elevated levels of Fra-2 and c-Jun proteins. We next tested the expression levels of c-fos, fra-2, c-jun, and junD mRNAs by RNase protection assay. As shown in Fig. 7, c- Although in this study we did not address the phosphorylation status of the c-Jun protein in vivo, several reports have indicated that phosphorylation of amino-terminal serines 63 and 73 of c-Jun accompanies the transformation of murine cells induced by v-src, activated c-Ha-ras, and activated raf-1, and it was also shown that phosphorylation is important for rat fibroblast transformation induced by high-level expressions of both c-jun and activated c-Ha-ras (2, 3, 34) . Two applicable to the chicken cell system. First, the N-terminal sites are apparently constitutively phosphorylated even in resting CEF and are only modestly affected by mitogenic stimulation. Second, a c-Jun mutant in which the N-terminal phosphorylation site is changed from a serine to an alanine residue retains the full activity to transform CEF as a single gene (24) .
Hyperphosphorylation of Fra-2 proteins, involving a mobility change, was detected in v-src-, c-Ha-ras-, and ND-raftransformed CEF. We previously reported similar phosphorylation of Fra-2 immediately after growth stimulation (39) . In CEF, both nonphosphorylated and phosphorylated (41-to 46-kDa) Fra-2 can be coimmunoprecipitated with c-Jun, and the resultant heterodimers seem to have equal specific DNA-binding activity. The 40-kDa Fra-2 protein synthesized in reticulocyte lysates also retains efficient dimerforming activity with c-Jun and binding activity to AP-1 sites. Although we would expect that phosphorylation contributes to the enhancement of transactivation activity, the effect of phosphorylation on transcriptional control, as well as the protein kinases responsible for Fra-2 phosphorylation, remains to be established. We would like to point out that these two transdominant mutants have the particular advantage that they are downstream in the signal transduction pathways (2), and both exhibit the blocking of cellular transformation caused by a wide range of oncogenes. Since supFos-1 and supJun-1 have only a modest effect on normal growth, we are now introducing these genes into primary cells to look for a differentiation process that involves endogenous AP-1 activation.
